E-health for Self-Management of Chronic Pain

Sponsor
Lund University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04628650
Collaborator
Weill Medical College of Cornell University (Other)
60
1
19
3.2

Study Details

Study Description

Brief Summary

The investigators aim to validate if a digital tool for increased self-management of chronic pain can improve the quality of life for patients with chronic pain. The validation is based on the change in pain interference (Quality of life), pain intensity, physical functioning, depression, and anxiety based on self-reported information from baseline to study end.

Condition or Disease Intervention/Treatment Phase
  • Device: Digital Pain-Management Tool

Detailed Description

Chronic pain is today an increasing health problem in both Europe and US, with an estimation of about 90 million people affected in Europe (Breivik, H. et al., 2006) and 100 million people in US (Relieving Pain in America, IOM Report 2011), or 20-30% of the adult population around the world. Chronic pain is defined as a condition that lasts for at least three to six months, after the normal healing period of an injury. Medical interventions offered in clinics around the globe are unfortunately not giving the results needed to give back the quality of life the patients had prior to the onset of the pain. The treatments offered today do sometimes reduce pain, but the effect is minor, and new treatment regimens are needed (Relieving Pain in America, 2011). Recent quality assurance registry measurements in Sweden has shown that patient taken part of multi modal treatment regimens, such as the acceptance and commitment therapy, (ACT) show that less then 40% of the patients have a decline in the pain level of 1 level on the VAS scale, 55% has no effect and 9 % has an increased level of pain after going through the program (Nationel Register for Pain Rehabilitation, Sweden 2017)

The study objective is to evaluate how the use of a digital pain coach, based on artificial intelligence that improves the self-management of pain will decrease the pain interference and thereby increase QoL among chronic pain patients, as measured by PROMIS pain interference 6a. We will here compare the improvement of quality of life by a decrease in pain interference, measured by PROMIS, in patients who follow their traditional treatment plan provided by the Pain Clinic with the addition of using a web application for increased self management of pain. The theory behind the study and the development of the device is supported by previously known data, showing that self-management has an effect and is important to the treatment by helping patients to believe in their own capacity to control their pain.

The present investigation aims at exploring the effect of including a digital tool as an add on to standard treatment and rehabilitation and will measure the effect it has on:

  1. Decreased pain interference

  2. Improved management of long-term pain and its consequences. Hence self-management of pain

  3. Increased function in daily life with the best possible activity and participation level

  4. Improved experience of health-related quality of life

  5. Decreased pain experience

Study Design

Study Type:
Observational
Anticipated Enrollment :
60 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Self-Management of Chronic Pain Using a Digital Pain-Management Tool.
Actual Study Start Date :
May 1, 2021
Anticipated Primary Completion Date :
Sep 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Outcome Measures

Primary Outcome Measures

  1. Pain interference [6 and 12 weeks from baseline]

    Change from baseline in pain interference (QoL), measured by PROMIS Pain Interference 6a . Measure of the amount of interference pain causes in life; range 6-30; higher is worse

Secondary Outcome Measures

  1. Pain severity [6 and 12 weeks from baseline]

    Change from Baseline in the 7 day average pain intensity. Measured by NRS using an 11-point Pain Intensity Numerical Rating Scale (NRS) (0=no pain, 10=pain as bad as you can imagine)

  2. Physical function [6 and 12 weeks from baseline]

    Change from baseline in physical function, measured with Patient-Reported Outcomes Measurement Information System (PROMIS) Physical function 10a. Measure of the impact of a condition on physical function; range 4-20; higher is worse

  3. Depression [6 and 12 weeks from baseline]

    Change from Baseline measured with Patient-Reported Outcomes Measurement Information System (PROMIS) Emotional Distress-Depression 4a. Measures the extent to which patients experience depressive symptoms over the past 7 days. Raw scores range from 4-20 with lower scores representing less endorsement of depression

  4. Anxiety [6 and 12 weeks from baseline]

    Change from Baseline measured with Patient-Reported Outcomes Measurement Information System (PROMIS) Emotional Distress - Anxiety 4. Measures the extent to which patients experience anxiety symptoms over the past 7 days. Raw scores range from 4-20 with lower scores representing less endorsement of anxiety.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Have a complex, prolonged axial neck pain or lower back pain

  • Have been followed by a pain management specialist for at least 3 months or have a history of chronic pain for at least 3 months as recorded by physician

  • Be >18 years of age

  • Have a goal and motivation that is adequate in relation to the program offered

  • Be medically prepared

  • Have no major change in interventional treatment or be a surgical candidate

  • Own a smart phone, tablet or computer or have the knowledge to use one

Exclusion Criteria:
  • Chronic pain requiring imminent surgical intervention

  • Reported severe or acute psychiatric illness, severe anxiety or depression

  • Current history of substance abuse

  • Serious health risks or scheduled major health interventions for other medical reasons

  • Pain related to malignancy

  • Pain duration <3 months

  • Other areas of pain exceeding the amount of back or neck pain

  • Not currently involved in lawsuit or pending litigation

Contacts and Locations

Locations

Site City State Country Postal Code
1 Weill Cornell Medicine New York New York United States 10065

Sponsors and Collaborators

  • Lund University
  • Weill Medical College of Cornell University

Investigators

  • Principal Investigator: Neel Metha, MD, Weill Cornell Medicine, Department of Anesthesiology

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Lund University
ClinicalTrials.gov Identifier:
NCT04628650
Other Study ID Numbers:
  • US2
First Posted:
Nov 13, 2020
Last Update Posted:
Apr 6, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Lund University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 6, 2022